The oral therapy is available through a REMS program.
Katelynn Tran, PharmD, BCPS
Advertisement
Articles by Katelynn Tran, PharmD, BCPS
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Zidesamtinib for Previously Treated ROS1-Positive NSCLC
2
mRNA COVID-19 Booster Outperforms Protein-Based Shot on Antibodies, But Both Cut Infections Over 12 Months
3
Navigating REMS: Challenges, Perspectives, and the Path Forward for Bispecific Antibody Programs
4
The Precision Prescription: How Automation Is Revolutionizing Medication Safety
5